Yini i-EnteraGam®?
I-EnteraGam® iyindlela yokwaziswa yokwelashwa kwesifo sohudo esibaluleke kakhulu kwi- IBS (IBS-D). Ihlukaniswa yi-FDA njengokudla kwezokwelapha okudingekayo kulokho okumelwe ukuthi kunqunywe udokotela wakho noma omunye umhlinzeki wezempilo onikezwe ilayisense. Umkhiqizo ungumquba oqukethe "isilumini esithathwe yi-serum-derived immunoglobulin / protein isolate" (SBI) futhi uthengiswa ngaphansi kwegama elithi "EnteraGam®".
Uxuba i-powder ibe yiketshezi uphinde uyiphuze.
I-SBI ekuqaleni yenzelwe ukusekela impilo yamathumbu emfuyweni yezilwane zasemapulazini, kodwa yakamuva ihlolwe ukwelashwa kwezifo (intestinal disease) kubantu, kuhlanganise nokubhekana nezihlalo ezivulekile nezivame kakhulu ze-IBS-D. Umkhiqizo ususelwa ezinkomeni futhi unamaprotheni cishe angu-90. Umkhiqizo awunamathele ezingeni lesisu noma emathunjini amancane , ukuze enze indlela yawo ihambelane emathunjini amakhulu .Inqubo ye-SBI ayicaciswanga ngokuphelele, kodwa izikhumba zezinyosi ezithuthukisiwe zingathuthukisa ukusebenza kahle kwepheshana le-GI . Iziguli ze-IBS zingase zibe nesifo sokuvuvukala, esingakaqondakali ngokucacile, ngakho-ke kungani ukusebenza kwe-EnteraGam® kungacacile.
Ucwaningo Luthini?
Nakuba kunobunye ubufakazi bokuthi i-SBI ingathuthukisa ukungena kwezilwane ezilwaneni, ezinye izivivinyo zokwelashwa zangaphambili zihlolwe umkhiqizo ozosetshenziswa kubantu, ikakhulukazi ukungenwa kwezingane ezinganeni, labo abane- HIV , kanye nabantu abane-IBS-D.
Ukuhlola okuncane, kodwa okungahleliwe, okuphindaphindiwe, okuyi-doublebo blindness, ekusetshenzisweni kwe-SBI ye-IBS-D, kubonise ukuthi ukusebenzisa umkhiqizo wamasonto ayisithupha kwaholela ekunciphiseni okukhulu kulezi zimpawu ezilandelayo:
Akukho nemiphumela emibi kakhulu eyabonakala, nakuba izifundo ezimbalwa zahamba ngenxa yesicashu.
Le miphumela kufanele ithathwe ngokucophelela okuncane. Kwakuyinkimbinkimbi encane, futhi iziguli eziseqenjini lokulawula nazo zathola ukuthuthukiswa kwesinye sezibonakaliso, okuphakamisa ukuthi kungenzeka yini umphumela we-placebo onomthelela.
Ukuhlolwa okuhlukile kuhlolwe ukuthuthukiswa kwesibonakaliso kwinombolo encane ye-IBS-D noma ye- IBS-M iziguli ezisebenzise umkhiqizo amasonto ayisithupha. Lokhu kwakungesiyo isifundo se-placebo esiphambanweni esiphambanweni. Ukuthuthukiswa kwesibindi kwahlangene cishe kwezintathu zabahlanganyeli. Ayikho imiphumela emibi eyaziwayo, nakuba iziguli ezimbalwa zayeka ukusebenzisa umkhiqizo ngenxa yemiphumela emibi njengokuqothulwa komzimba, isifo sohudo kanye nesicanucanu.
Ngethemba ukuthi ukucwaninga kwesikhathi esizayo kuzokwenza kube lula ukusizwa kokungena kwe-EnteraGam® njengendlela yokwelapha esebenzayo ye-IBS-D.
Kuyasiza Kanjani?
Ngokusekelwe ocwaningweni kuze kube yimanje (isilwane nabantu) i-SBI icatshangwa ukuthi kungenzeka:
- Nika izinzuzo zokudla okunomsoco.
- Ukubopha ngezidakamizwa emanzini.
- Ukunciphisa ama-cytokines abangela ukuvuvukala.
- Ukusekela isimiso somzimba.
- Nciphisa ukunyuka kwamathumbu emathunjini (i-leaky gut syndrome).
- Thuthukisa ukulinganisela kwe-flora.
Ingabe Kuphephile?
I-EnteraGam® ibhekwe yi-FDA ngokuthi "Ngokujwayelekile Iyabonakala Njenokuphepha." Akufanele isetshenziswe ngabantu abaphikisayo kwenkomo. Akukaze kuhlolwe ngokuphepha kumama okhulelwe noma ohlengikazi noma labo abane-immune system.
Ihlolwe ezincwadini ezincane zokusetshenziswa nezinsana nezingane ezingenazo imiphumela emibi emibi evezwe.
Ingabe i-EnteraGam® Kulungile?
Nakuba ucwaningo lwe-EnteraGam® lusesiteji sokuqala, ngokuqinisekile lubukeka luthembise ngokuhlinzeka ukwelashwa okuphephile futhi okungenzeka kube nokwelapha okuphumelelayo kwe-IBS-D. Uma izimpawu zakho zingaphenduki kwamanye amasu okuphatha, ungase ufune ukukhuluma nodokotela wakho mayelana nokuzama.
Imithombo:
I-Petschow, B., et.al. "Iprovinti ye-bovine immunoglobulin ihlukanisa ukuphathwa kokudla okunomsoco we-enteropathy." I- World Journal of Gastroenterology 2014 20: 11713-11726.
I-Petschow, B., et.al. "I-Serum-derived bovine immunoglobulin / amaprotheni eyodwa: indlela ehlelwe ngayo yesenzo sokuphathwa kwe-enteropathy" Gastroenterology Clinical and Experimental 2014 7: 181-190.
Weinstock, J. & Jasion, V. "I-Serum-Derived Bovine Immunoglobulin / Protein Isolate Therapy for Iziguli ezine-Refractory Irritable Bowel Syndrome" Open Journal of Gastroenterology 2014 4: 5 amakhasi.
Wilson, D., et.al. "Ukuhlolwa kwesiprotheni se-Serum-Derived Bovine Immunoglobulin Isolate kwizihloko ezinesifo sohudo-i-Irritable Bowel Syndrome" ebizwa ngokuthi i-Predominant Irritable Bowel Syndrome " Clinical Medical Insights: I-Gastroenterology 2013 6: 49-60.